ARTICLE | Clinical News
Vasopermeation Enhancement Agent regulatory update
January 10, 2000 8:00 AM UTC
The University of Southern California (Los Angeles, Calif.) received U.S. Patent No. 6,007,817 covering the use of VEA technology to treat solid tumors in combination with chemotherapy, monoclonal ant...